Dr. Rosén is principal investigator behind the national clinical trial "DIRECT - DIRECT INFORMATION TO AT-RISK RELATIVES: A RANDOMISED CONTROLLED TRIAL", which aims to develop and evaluate an intervention focusing on enhanced information disclosure to at-risk relatives in families with an increased hereditary risk of developing breast, ovarian or colorectal cancer. Dr. Rosén has received a FORTE grant as a Junior Researcher for 2019-2022. The overall project is also supported by the Cancer Research Foundation in Norrland, the Swedish Breast Cancer Association, and the regional agreement between Umeå University and Västerbotten County Council (Projektmedel centrala ALF, kategori yngre forskare samt basenhets-ALF).